Skip to contentC
Cryo Cell International Inc
C
CCELCryo Cell International Inc Q3 2025 · 10-Q
Revenue$7.83M$7.83M−3.0% vs Q3 2024 Net Income$749.41K$749.41K−28.7% vs Q3 2024 EPS Diluted$0.09$0.09−30.8% vs Q3 2024 Operating Income$1,900,536+36.7% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cryo Cell International Inc · CIK 862692 · Engraved from SEC EDGAR
derived
Free Cash Flowderived$2,497,928+10.9% Margins · derivedOperating margin24.3%+7.1 pt vs Q3 2024
Net margin9.6%−3.5 pt vs Q3 2024
ended Aug 31, 2025 · filed Oct 15, 2025 · 45 d after period end